Zacks Investment Research on MSN22h
OPTN Stock Soars 53% on Inking $330M Deal to be Acquired by ParatekShares of OptiNose OPTN soared 52.5% on Thursday after the company announced that it is set to be acquired by Paratek ...
Zacks Investment Research on MSN21h
Alnylam Gets FDA Nod for Expanded Use of Amvuttra in CardiomyopathyAlnylam Pharmaceuticals ALNY announced that the FDA had approved its regulatory filing seeking the label expansion of its ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback